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Vil. IMMUNOLOGICAL EFFECTIVENESS OF THE TWO DOSE SCHEDULEt
The immunological effectiveness of the Middletown oral poliovirus vac-
cination program was determined by testing pre- and post-vaccinal neutral-
izing antibody levels in blood specimens from a selected group of children,
representing about five per cent of the school children and 10 per cent of
the preschool vaccinees. The present paper is concerned with the results of
these tests in terms of the antibody status of the study group before they
received oral vaccine, the conversion rates in antibody-negative children,
and antibody rises in those with low levels before oral vaccination.
MATERIALS AND METHODS
Selection of children for antibody survey and collection of specimens.
The plan was to obtain blood specimens from approximately 600 children,
200 from each of three socio-economic classes. Actually, 682 were bled at
the time the first dose of vaccine was given. Post-vaccinal specimens, col-
lected approximately six weeks after the second dose, were obtained from
676 of this group. Satisfactory antibody tests were completed on 671 paired
specimens, which form the basis for the analyses to be presented.
Most of the 671 children included came from the randomly selected
families in the interview sample,' but it was necessary to enlarge the "upper"
and "lower" socio-economic categories, both in school age and preschool
groups. This was done with the aid of the city directory, school nurses,
and the Board of Education's preschool census. Questionnaires were filled
out for all children surveyed. The information obtained included the number
of injections of Salk-type vaccine received and the dates on which they
were given. Data on the vocation and educational level of the family head
were recorded also, for the purpose of social classification of the vaccinees,
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using the Hollingshead two-factor scale.' This classification designates five
social classes, class I being the highest and class V the lowest. For our
purposes it was sufficient to consider combined classes I and II as "upper,"
III and IV as "middle," and class V as "lower" socio-economic groups. The
composition of the population surveyed serologically is shown by age and
social class in Table 1, and by the number of doses of Salk-type vaccine
received, in Table 2.
TABLE 1. COMPOSITION OF GROUPS SURVEYED SEROLOGICALLY,
BY AGE AND SOCIAL CLASS
Number in each age group
Social class Number <1-4 5-9 10-14 15-19
I & II 165 74 31 34 26
III & IV 321 157 44 65 55
V 185 73 31 51 30
Total 671 304 106 150 111
TABLE 2. VACCINATION HISTORY, BY AGE AND DOSES OF
INACTIVATED VACCINE
Number of doses-per cent with:
Age Number 0 1 2 3 4
<1-4 304 4 5 14 41 36
5-9 106 0 0 5 34 61
10-14 150 3 0 1 34 62
15-19 111 2 2 6 53 37
Total 671 3 3 8 40 46
Antibody determinations. The micromethod of Green and Opton' using
finger blood collected on filter paper was employed. Paired specimens
were tested in monkey-kidney tissue-culture tubes, with appropriate chal-
lenge doses of the three types of poliovirus. The sensitivity of this method
is roughly comparable to that of the tube neutralization test in which
dilutions of serum and 100 TCD.0 of virus are incubated for one hour at
room temperature before inoculation. Both methods depend upon inhibition
of cytopathic effect (CPE), and as has been pointed out previously"4 low
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titers of antibody (1: 8 or less) which would be revealed by the colorime-
teric (pH) method of measuring neutralizing antibody may be missed.
RESULTS
Pre-vaccinal antibody survey. As shown in Table 2, the children had been
well vaccinated with Salk-type vaccine, 86 per cent having received three
or more injections. Their antibody patterns for the three types of poliovirus
TABLE 3. ANTIBODY PATTERNS (EXPRESSED QUALITATIVELY AS POSITIVE
OR NEGATIVE) AFTER SALK-TYPE VACCINE, BUT PRIOR TO
ORAL VACCINE ADMINISTRATION.
Number of Number of Per cent wuith antibodies to:*
Age doses children Type I Type II Type III
<1-4 0-2 71 25 37 23
3 124 59 72 47
4 109 69 83 48
5-9 0-2 5 (80)* (80) (60)
3 36 64 92 44
4 65 82 98 46
10-14 0-2 5 (60) (80) (20)
3 52 81 96 52
4 93 95 99 71
15-19 0-2 11 70 90 50
3 59 85 97 61
4 41 90 100 68
* Figures in parentheses are not of statistical significance.
are shown in Table 3, by age and the number of injections of inactivated
vaccine which they had received. As had been observed in a previous study
carried out in New Haven, Conn.,' a considerable percentage of the
children, particularly the preschool group, lacked antibody to one or more
types in spite of multiple doses of Salk-type vaccine. The less satisfactory
response of this youngest age group to inactivated vaccine as compared to
school-age children is also evident from this table. The low per cent with
type III antibodies is doubtless in part due to the test method used,' although
the relatively poorer antigenicity of type III Salk vaccine is probably also
a factor. Analysis of antibody patterns in terms of social class showed no
significant differences.
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Antibody responses induced by oral vaccine. Following the administration
of two doses of oral vaccine, homotypic negative children showed high
conversion rates for all three types, as shown in Table 4. From 99 to 100
per cent of children aged <1 to 9 years developed antibodies to types I and
II, and 89 per cent to type III. A lower percentage of older individuals
(15-19 years) develop antibodies-81 per cent for type I, and 66 per cent
for type III. In general, post-oral-vaccine antibody titers were high,
the majority being 1: 512 or greater.* These results confirm many
TABLE 4. ANTIBODY CONVERSIONS* IN HOMoTYPIc NEGATIVES
AFTER ORAL VACCINE
Type I Type II Type III
No. Per cent No. Per cent No. Per cent
Age No. neg.** conversions neg.** conversions neg.** conversions
<1-4 304 146 99 99 100 178 89
5-9 106 26 100 5 100 57 89
10-14 150 17 100 4 100 56 79
15-19 111 16 81 3 100 41 66
Total 671 205 98 111 100 332 83
*To a level of 1:16 or higher.
** Neg. = lacking pre-oral-vaccination antibodies.
previous observations on the high degree of immunological effectiveness of
the Sabin vaccine,' particularly in young children. The excellent responses
to two doses, i.e. type I followed after six weeks by types II and III to-
gether, are in line with our earlier observations' and with the experience of
others.'
The lower rate of conversions among older individuals as compared
with younger children, has been noted by others.7 An explanation for this
is not entirely clear, but several possible factors may be involved. One is
that certain adults who lack demonstrable antibody nevertheless have been
infected previously and, as a result, have a high degree of intestinal re-
sistance to re-infection.' Another point to be considered is that the greater
probability of contact infection among young children may be responsible
for increasing the conversion rates in this age group. However, if this
latter factor played a major role, one might expect a greater difference
* In the following discussion, "titers" refer to estimated neutralizing antibody levels
based on standards worked out for the filter paper micromethod.3
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between preschool and older children;8 instead the decline in conversion
rates is striking only in those over 14 years, and particularly in young
adults.
Antibody rises in children with low level pre-oral-vaccine titers. As
indicated in Table 5, a high percentage of children with titers of 1: 8 to
1: 32 against one or more types of poliovirus showed sharp rises in titer
after oral vaccination, the levels reached being in the 1: 512 - 1:1024 or
higher range in the majority of instances. In general, it is likely that such
low pre-oral-vaccinal titers represent antibodies induced by Salk-type
TABLE 5. ANTIBODY RIsES (FOURFOLD OR GREATER) IN CHILDREN WITH
PRE-ORAL-VACCINE TITERs OF 1: 8 TO 1: 32
Type I Type II Type III
Number Per cent Number Per cent Number Per cent
Age of wvith anti- of zewth anti- of with anti-
group children body rise children body rise children body rise
<1-4 38 94 37 97 39 90
5-9 13 92 8 100 19 74
10-14 16 94 14 100 20 70
15-19 21 76 9 67 12 67
Total 88 90 68 94 90 79
vaccine alone, while levels of 1: 64 or higher are more apt to have been
induced by previous natural inapparent infection enhanced, in some, by
vaccine injections. It is not surprising, therefore, that the majority of
children listed in Table 5 showed sharp antibody rises after receiving oral
vaccine, since it has been well established that inactivated vaccine does not
confer significant intestinal resistance to infection. Thus in 90 per cent of
the children, rises to type I occurred, in 94 per cent to type II, and in 79
per cent to type III. In previous studies, such rises have been shown to be
associated invariably with virus excretion; it is thus likely that the present
results are due to actual infection, and not to heterotypic responses.
Comparison between responses to oral vaccine and to Salk-type vaccine.
As has been observed previously,"9 in spite of multiple doses of Salk-type
vaccine given prior to the oral vaccine campaign, a significant number of
children lacked adequate antibody levels against one or more types of polio-
virus (Table 3). This was most striking in the preschool age group, i.e.
among young children who had not yet had time to experience natural in-
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fection with wild polioviruses to enhance their antibody levels acquired
from Salk-type vaccine (or vice-versa). Thus in spite of four doses of
inactivated vaccine, 31, 17, and 52 per cent of children aged <1-4 lacked
antibody to type I, II, and III respectively. Among older children with com-
parable vaccine histories, these figures were considerably lower, particularly
for types I and II; presumably, these differences reflected the greater op-
portunity with increasing age to acquire natural infection. A higher per
cent of all age groups lacked type III antibody as compared with the other
types, a pattern observed before, and related in part at least to the poorer
antigenicity of the type III component of Salk-type vaccine.
Following oral vaccination, the responses were remarkably good in terms
of antibody conversions and rises, and high titers were the rule. Based on
our previous experiences with immunization of young children' there is
reason to expect that the high titers reached will persist without greater
decline than would be expected to follow natural infection with wild
poliovirus strains.
These results emphasize the desirability of oral poliovirus vaccine, even
in a community as well covered by inactivated vaccine as was Middletown.
SUMMARY
The immunological effectiveness of the Sabin strains of oral poliovirus
vaccine given in two doses (type I, followed after six weeks by types II
and III) was determined by measuring the serological responses of 671
vaccinees of different age and social class. Even though 86 per cent had
received three or more doses of Salk-type vaccine, a number of children
lacked significant antibody to one or more types. The responses to oral
vaccine were certainly satisfactory. Conversion rates in antibody-negative
children were uniformly high: 98 per cent for type I, 100 per cent for type
II, and 83 per cent for type III. The highest rates were observed in pre-
school children, and the lowest in those aged 15-19 years. Children with low
level pre-oral-vaccine titers (presumably resulting from Salk-type vaccine)
responded with rises to high titers: 90 to 94 per cent for types I and II, and
79 per cent for type III. No significant differences were noted in the pre- or
post-oral-vaccine antibody patterns according to social class.
The results again emphasize the immunological effectiveness of the oral
poliovirus vaccine and its superiority over the Salk-type vaccine in achieving
higher conversion rates and higher antibody levels. This was evident in
Middletown, even though inactivated vaccine had been widely used, for
many children lacked antibodies in spite of having received multiple in-
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jections. In contrast, a single exposure to each of the three types of oral
vaccine corrected the deficits in a high percentage of children.
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